Level C· Early human research exploring benefitsCohort StudyEurope PMCOpen access

Alginate encapsulated cell blocks improve diagnostic consistency and long term specimen integrity in routine pathological diagnostics and cancer research

Borowczak J., Kula M., Gostomczyk K., Olejnik K., Drozd M., Kostrzewska-Poczekaj M.

Cohort Study, published in Sci Rep (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Cohort Study
Journal
Sci Rep (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41152457
PMCID
PMC12568939
DOI
10.1038/s41598-025-21615-0

Abstract (original English)

Cell blocks help preserve cytological material and facilitate ancillary diagnostics, but their accuracy is often compromised by uneven cell distribution and interference with immunohistochemical staining. We present an internally validated protocol for alginate-encapsulated cell blocks, which have been successfully used in routine pathology and during cancer research studies. Harvested cells were suspended in phosphate-buffered saline and centrifuged. Cell pellets were mixed with an alginate solution, immersed in 0.1 M calcium chloride to form conglomerates, fixed in 10% buffered formalin, processed in a tissue processor, embedded in paraffin, sectioned, and subjected to routine diagnostic protocols. Implementing alginate-encapsulated cell blocks in our laboratory allowed for the evaluation of pleural effusion, peritoneal effusion, and bronchial washings, with the cytopathological diagnoses matching the histopathological diagnoses in over 95% of cases analyzed. Cell blocks were internally validated against results obtained from histopathologic specimens and did not require manufacturer-provided kits. We have successfully applied the protocol to characterize the newly established mucoepidermoid carcinoma cell line (IHG-MUC360) expressing GOPC, with potent use in in vitro and in vivo studies. Integrating alginate encapsulation and cell block preparation significantly advances cyt

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Cell Line, TumorAnimalsHumansNeoplasmsCarcinoma, MucoepidermoidAlginatesSpecimen Handling

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.